About Us

Message from the Director


Dr. Kirkpatrick in the labThe Vaccine Testing Center and its laboratories are dedicated to improving global health through the development and study of new vaccines and by improving our understanding of how humans respond immunologically to infections and vaccines.


Vaccine Development

As part of the UVM Department of Microbiology and Molecular Genetics, the Vaccine Testing Center (VTC) team runs a fully functioning unit for performing phase I and II vaccine trials and enteric challenge models. In general, the VTC focuses on the development of vaccines of importance to global health, including typhoid fever, Campylobacter infections, dengue virus infections, cholera, rotavirus and polio infections. In 2009, the VTC began a 10-year project with Johns Hopkins and the National Institutes of Health's Laboratory of Infectious Diseases to study new Dengue vaccines. Other collaborators have included biotech companies, the National Institutes of Health and the Department of Defense.

Our laboratories are outfitted for scaled-up clinical immunology and microbiology work. Our staff is trained in current Good Clinical Practices (GCP) according to FDA E9 specifications and the laboratory operates on Good Clinical Laboratory Practice (GCLP) principles. Laboratories have the capacity for performing the immunogenicity work for multi-site vaccine trials, including specimen processing and storage. We also have the flexibility to add study-specific assays needed for vaccine trials. A detailed description of available equipment is available upon request. Experienced technicians are trained to perform validated immunologic and microbiology assays including: ELISAs, ELISPOT/ ASC/ ALS assays, functional assays of opsonization, PCR, multi-parameter flow cytometry and cell sorting, cytokine analysis (Bioplex), confocal microscopy, plaque-based assays for viral pathogens, bacterial culturing, and inoculum preparation for challenge studies.

Infectious Disease Immunology

In addition to vaccine testing, the VTC team is interested in characterizing how the human host responds immunologically to clinically important infectious agents and vaccines. The goal of this work is to gain a better understanding of immunologic responses to vaccines as well as natural infections.

For details about recruitment for ongoing studies see Volunteer for Research.

Beth Kirkpatrick, M.D.
Professor of Medicine
Director, Vaccine Testing Center

Chairperson, Department of Microbiology & Molecular Genetics 

VTC Faculty and Staff Group Photo 2017

The Vaccine Testing Center Team, 2017 

Donate Here